Insights

Strategic Focus Shift Pharmaceuticals specializes in antisense oligonucleotides for genetic disorders such as Charcot Marie Tooth Syndrome (CMT1A) and Spinal Muscular Atrophy (SMA), presenting opportunities to engage with researchers and patient advocacy groups in rare disease spaces and to align partnerships with targeted gene therapy initiatives.

Funding Leverage Strong grant and foundation support from NIH, DoD, CMT Research Foundation, and Gwendolyn Strong Foundation can be leveraged to identify co-development or grant-funded collaboration opportunities, potentially accelerating early-stage collaborations with larger biotech and contract development organizations.

Partnership Potential With a small team and early-stage revenue profile, there is room to propose services such as translational biology support, preclinical assay development, and regulatory consulting through CROs or biotech partners seeking to expand antisense oligo portfolios.

Technology Footprint Utilize their current web and content stack (WordPress, oEmbed, RSS) as channels for thought leadership and outreach campaigns; target academic labs and industry newsletters that focus on genetic disorders and nucleic acid therapeutics to raise visibility and collaboration interest.

Market Positioning Position Shift Pharmaceuticals as an emerging, mission-driven antisense platform in rare diseases to engage large pharma as a potential co-development or licensing partner, highlighting a core disease-modifying approach that aims to address root causes rather than symptomatic relief.

Similar companies to Shift Pharmaceuticals

Shift Pharmaceuticals Tech Stack

Shift Pharmaceuticals uses 8 technology products and services including RSS, WordPress, oEmbed, and more. Explore Shift Pharmaceuticals's tech stack below.

  • RSS
    Content Management System
  • Content Management System
  • oEmbed
    Dev Tools
  • Google Fonts API
    Font Scripts
  • jQuery Migrate
    Javascript Libraries
  • Contact Form 7
    Web Platform Extensions
  • Apache
    Web Servers
  • Apache HTTP Server
    Web Servers

Shift Pharmaceuticals's Email Address Formats

Shift Pharmaceuticals uses at least 1 email format:
Shift Pharmaceuticals Email FormatsExamplePercentage
First.Last@shiftpharmaceuticals.comJohn.Doe@shiftpharmaceuticals.com
100%

Frequently Asked Questions

What is Shift Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign icon
Shift Pharmaceuticals's official website is shiftpharmaceuticals.com and has social profiles on LinkedIn.

How much revenue does Shift Pharmaceuticals generate?

Minus sign iconPlus sign icon
As of September 2026, Shift Pharmaceuticals's annual revenue is estimated to be <$1M.

What is Shift Pharmaceuticals's NAICS code?

Minus sign iconPlus sign icon
Shift Pharmaceuticals's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Shift Pharmaceuticals have currently?

Minus sign iconPlus sign icon
As of September 2026, Shift Pharmaceuticals has approximately 4 employees across 1 continents, including North America. Key team members include Chief Executive Officer: S. O. Explore Shift Pharmaceuticals's employee directory with LeadIQ.

What industry does Shift Pharmaceuticals belong to?

Minus sign iconPlus sign icon
Shift Pharmaceuticals operates in the Pharmaceutical Manufacturing industry.

What technology does Shift Pharmaceuticals use?

Minus sign iconPlus sign icon
Shift Pharmaceuticals's tech stack includes RSS, WordPress, oEmbed, Google Fonts API, jQuery Migrate, Contact Form 7, Apache and Apache HTTP Server.

What is Shift Pharmaceuticals's email format?

Minus sign iconPlus sign icon
Shift Pharmaceuticals's email format typically follows the pattern of First.Last@shiftpharmaceuticals.com. Find more Shift Pharmaceuticals email formats with LeadIQ.
Shift Pharmaceuticals logo

Shift Pharmaceuticals

Pharmaceutical ManufacturingKansas, United States2-10 Employees

Shift Pharmaceuticals is a pharmaceutical manufacturing company based in Overland Park, Kansas. The firm focuses on developing Antisense Oligonucleotide drug candidates aimed at correcting the underlying causes of genetic disorders, with potential applications for conditions such as Charcot Marie Tooth Syndrome and Spinal Muscular Atrophy. By targeting disease at the level of protein production, the company seeks to realign normal protein expression rather than merely addressing individual symptoms. Its activities place it within the biotechnology and gene therapy segment of the pharmaceutical industry, emphasizing precision approaches to genetic diseases. The company operates with a small team and is supported by collaborations and partnerships within the broader research community.

Section iconCompany Overview

NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
2-10

Section iconFunding & Financials

  • <$1M

    Shift Pharmaceuticals's revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.